Literature DB >> 31970766

Duration of oxaliplatin-based adjuvant chemotherapy in patients with Stage III or high-risk Stage II resected colon cancer.

Roberto Moretto1,2, Alfredo Falcone1,2, Chiara Cremolini1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31970766     DOI： 10.1002/ijc.32884

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  3 in total

1.  The effect of comprehensive nursing on the recovery speed and prognosis of elderly colon cancer patients.

Authors:  Jingjing Wu; Chuanling Wei; Fengxia Li; Xiling Wang; Fang Sun
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  Model-based evaluation of the cost effectiveness of 3 versus 6 months' adjuvant chemotherapy in high-risk stage II colon cancer patients.

Authors:  Gabrielle Jongeneel; Marjolein J E Greuter; Felice N van Erning; Miriam Koopman; Geraldine R Vink; Cornelis J A Punt; Veerle M H Coupé
Journal:  Therap Adv Gastroenterol       Date:  2020-09-16       Impact factor: 4.802

3.  Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients.

Authors:  Gabrielle Jongeneel; Marjolein J E Greuter; Felice N van Erning; Miriam Koopman; Geraldine R Vink; Cornelis J A Punt; Veerle M H Coupé
Journal:  Therap Adv Gastroenterol       Date:  2021-03-12       Impact factor: 4.409
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.